SLC2As as diagnostic markers and therapeutic targets in LUAD patients through bioinformatic analysis
出版年份 2022 全文链接
标题
SLC2As as diagnostic markers and therapeutic targets in LUAD patients through bioinformatic analysis
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 13, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-11-28
DOI
10.3389/fphar.2022.1045179
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- m6A-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD
- (2021) Feng Xu et al. Molecular Therapy-Nucleic Acids
- Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma
- (2020) Zedan Zhang et al. Cancer Cell International
- Elevated SLC2A1 Expression Correlates with Poor Prognosis in Patients with Surgically Resected Lung Adenocarcinoma: A Study Based on Immunohistochemical Analysis and Bioinformatics
- (2020) Wei Guo et al. DNA AND CELL BIOLOGY
- Exploration of a novel prognostic risk signatures and immune checkpoint molecules in endometrial carcinoma microenvironment
- (2020) Jinhui Liu et al. GENOMICS
- Permuted 2,4-thiazolidinedione (TZD) analogs as GLUT inhibitors and their in-vitro evaluation in leukemic cells
- (2020) Kalpana Tilekar et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Structure, function and regulation of mammalian glucose transporters of the SLC2 family
- (2020) Geoffrey D. Holman PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Power of two: Combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancer
- (2020) Kalpana Tilekar et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets
- (2020) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
- (2019) Yingyao Zhou et al. Nature Communications
- Nomogram for predicting gastric cancer recurrence using biomarker gene expression
- (2019) Sang-Ho Jeong et al. EJSO
- Current Perspectives in Cancer Immunotherapy
- (2019) Theodoulakis Christofi et al. Cancers
- Correlations between the metabolic profile and 18F-FDG-Positron Emission Tomography-Computed Tomography parameters reveal the complexity of the metabolic reprogramming within lung cancer patients
- (2019) Karolien Vanhove et al. Scientific Reports
- An outcome model for human bladder cancer: A comprehensive study based on weighted gene co‐expression network analysis
- (2019) Yaoyi Xiong et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Immunotherapy: Cancer immunotherapy and the value of cure
- (2018) Joseph C. Del Paggio Nature Reviews Clinical Oncology
- Fructose fuels lung adenocarcinoma through GLUT5
- (2018) Yuanyuan Weng et al. Cell Death & Disease
- A panel of DNA methylation markers for the detection of prostate cancer from FV and DRE urine DNA
- (2018) Igor Brikun et al. Clinical Epigenetics
- Involvement of GLUT1-mediated glucose transport and metabolism in gefitinib resistance of non-small-cell lung cancer cells
- (2018) Shuhei Suzuki et al. Oncotarget
- RDM1 plays an oncogenic role in human lung adenocarcinoma cells
- (2018) Lu Tong et al. Scientific Reports
- Targeting ulcerative colitis by suppressing glucose uptake with ritonavir
- (2018) Henrika Jodeleit et al. Disease Models & Mechanisms
- Sensitive tumour detection and classification using plasma cell-free DNA methylomes
- (2018) Shu Yi Shen et al. NATURE
- Altered cancer metabolism in mechanisms of immunotherapy resistance
- (2018) Rishab Ramapriyan et al. PHARMACOLOGY & THERAPEUTICS
- A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer
- (2018) Fang Zhao et al. Clinical Epigenetics
- Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells
- (2017) Varun Sasidharan Nair et al. IMMUNOLOGY AND CELL BIOLOGY
- Upregulation of SLC2 (GLUT) family genes is related to poor survival outcomes in papillary thyroid carcinoma: Analysis of data from The Cancer Genome Atlas
- (2017) Young Jun Chai et al. SURGERY
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- Anticancer agents interacting with membrane glucose transporters
- (2016) C. Granchi et al. MedChemComm
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- Normalization of CD4 + T cell metabolism reverses lupus
- (2015) Yiming Yin et al. Science Translational Medicine
- ErbB2 Pathway Activation upon Smad4 Loss Promotes Lung Tumor Growth and Metastasis
- (2015) Jian Liu et al. Cell Reports
- Could GLUT12 be a Potential Therapeutic Target in Cancer Treatment? A Preliminary Report
- (2015) Jonai Pujol-Gimenez et al. Journal of Cancer
- Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer Progression
- (2015) Ang Yuan et al. Scientific Reports
- The Glucose Transporter Glut1 Is Selectively Essential for CD4 T Cell Activation and Effector Function
- (2014) Andrew N. Macintyre et al. Cell Metabolism
- AMPK: Regulating Energy Balance at the Cellular and Whole Body Levels
- (2014) D. Grahame Hardie et al. PHYSIOLOGY
- Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
- (2014) Theerawut Chanmee et al. Cancers
- Oxime-based inhibitors of glucose transporter 1 displaying antiproliferative effects in cancer cells
- (2013) Tiziano Tuccinardi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK
- (2013) Y Storozhuk et al. BRITISH JOURNAL OF CANCER
- The SLC2 (GLUT) family of membrane transporters
- (2013) Mike Mueckler et al. MOLECULAR ASPECTS OF MEDICINE
- Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake
- (2013) William A Flavahan et al. NATURE NEUROSCIENCE
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- (2013) Balázs Győrffy et al. PLoS One
- A Small-Molecule Inhibitor of Glucose Transporter 1 Downregulates Glycolysis, Induces Cell-Cycle Arrest, and Inhibits Cancer Cell Growth In Vitro and In Vivo
- (2012) Y. Liu et al. MOLECULAR CANCER THERAPEUTICS
- Impact of GLUT1 and Ki-67 expression on early-stage lung adenocarcinoma diagnosed according to a new international multidisciplinary classification
- (2012) YUHO MAKI et al. ONCOLOGY REPORTS
- Chronic modulation of AMP-Kinase, Akt and mTOR pathways by ionizing radiation in human lung cancer xenografts
- (2012) Yaryna Storozhuk et al. Radiation Oncology
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Inhibition of Glycolytic Enzymes Mediated by Pharmacologically Activated p53
- (2011) Joanna Zawacka-Pankau et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cytoscape 2.8: new features for data integration and network visualization
- (2010) M. E. Smoot et al. BIOINFORMATICS
- Ionizing Radiation Activates AMP-Activated Kinase (AMPK): A Target for Radiosensitization of Human Cancer Cells
- (2010) Toran Sanli et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Uric acid transport and disease
- (2010) Alexander So et al. JOURNAL OF CLINICAL INVESTIGATION
- Assessment of factors influencing FDG uptake in non-small cell lung cancer on PET/CT by investigating histological differences in expression of glucose transporters 1 and 3 and tumour size
- (2010) Naohisa Suzawa et al. LUNG CANCER
- Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation
- (2010) Giovanni L Gravina et al. Molecular Cancer
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
- (2009) Zvi G. Fridlender et al. CANCER CELL
- GLUT7: a new intestinal facilitated hexose transporter
- (2008) Chris Cheeseman AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search